← Human Trials & Peer-Reviewed Studies

The effect of vitamin D supplementation on pain: an analysis of data from the D-Health randomised controlled trial.

Plain-language guide to PMID 36426546 (2023): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 21 participants.

Key Facts

PMID
36426546
Journal
The British journal of nutrition
Year
2023
Study type
Randomized Controlled Trial
Authors
Rahman A et al. (16 authors)
DOI
10.1017/S0007114522003567

What This Study Did, in Plain Language

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

However, findings from intervention trials are inconsistent.

The researchers used regression models (linear for continuous PIQ-6 score and log-binomial for binary categorisations of the score, namely 'some or more pain impact' and 'presence of any bodily pain') to estimate the effect of vitamin D on pain.

Who Took Part

According to the abstract, 21 participants were involved.

Pain was measured using the six-item Pain Impact Questionnaire (PIQ-6), administered 1, 2 and 5 years after enrolment.

How the Study Was Run

In design terms this was a randomized, double-blind and placebo-controlled study.

The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.

The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.

What Was Measured

The researchers used regression models (linear for continuous PIQ-6 score and log-binomial for binary categorisations of the score, namely 'some or more pain impact' and 'presence of any bodily pain') to estimate the effect of vitamin D on pain.

Topics PubMed links to this paper include Vitamin D, Cholecalciferol, Vitamins, Pain, Vitamin D Deficiency and Dietary Supplements.

The authors tagged it with the keywords Bodily pain, Chronic pain, PIQ-6, Randomised controlled trial and Vitamin D3.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 21 participants.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 2023 (The British journal of nutrition), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.